Skip to main content
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
309.60
+3.80 (1.24%)
At close: Dec 5, 2025

Novo Nordisk Revenue

Novo Nordisk had revenue of 74.98B DKK in the quarter ending September 30, 2025, with 5.14% growth. This brings the company's revenue in the last twelve months to 315.60B, up 16.64% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
315.60B
Revenue Growth
+16.64%
P/S Ratio
4.36
Revenue / Employee
4.02M
Employees
77,349
Market Cap
1,375.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coloplast 27.87B
Genmab 24.48B
ALK-Abelló 6.08B
Demant 22.59B
H. Lundbeck 24.08B
Zealand Pharma 9.16B
Ambu A/S 6.04B
Embla Medical 5.71B
Revenue Rankings

Novo Nordisk News

More News